Encompass Health Corporation
NYSE:EHCMedical - Care Facilities
-$1.95 today
- Market cap
- $13.24B
- Beta
- 0.59
- P/E (TTM)
- 15.9
- EPS (TTM)
- $6.14
- Dividend yield
- 0.76%
Volume 0.84M
Average 0.92M
EHC Account Payables
Amounts the company owes suppliers for goods and services received.
Encompass Health CorporationNYSE: EHC
Account Payables · Q2 FY2026 · quarter ended Jun 2026
Account payables rises 27.0% from a year ago
Account payables stood at $221.6M at the end of Q2 FY2026, up 27.0% from a year earlier and up 8.6% from the prior quarter. Over 3 fiscal years it compounded at +10.3% a year.
Context
- Account payables amounted to 3.0% of total assets at the end of Q2 FY2026, up 0.4 pp from a year earlier.
- Account payables increased in 3 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether account payables keeps rising in the next quarterly balance sheet after a +27.0% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Account Payables history
USD · from the balance sheet
- Latest · FY2025
- 178.2M USD
- Year-over-year change
- +4.2%
- 4-year CAGR
- +7.4%
| Period | Period end | Account Payables | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 178.2M | +4.2% |
| FY2024 | 2024-12-31 | 171M | +0.6% |
| FY2023 | 2023-12-31 | 170M | +27.9% |
| FY2022 | 2022-12-31 | 132.9M | -0.8% |
| FY2021 | 2021-12-31 | 134M | — |
Account Payables vs competitors
How EHC compares with its peers on the latest reported figures
- EHC's Jun 2026 account payables of $221.6M is the 2nd highest of the 9 companies compared; the peer median is $46.11M.
- Its year-over-year change of +27.0% is the 2nd highest of 9, against a peer median of +10.9%.
- Account payables amounts to 3.0% of total assets for EHC, versus a peer median of 2.2%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Sep 2026 | $670.68M | +6.8% | +19.1% | 19.3% | |
| Jun 2026 | $221.6M | +27.0% | +10.3% | 3.0% | |
| Jun 2026 | $160.88M | -6.5% | +20.2% | 2.8% | |
| Jun 2026 | $119.68M | +16.4% | +8.1% | 2.1% | |
| Jun 2026 | $50.41M | -0.9% | +8.5% | 3.2% | |
| Oct 2026 | $41.8M | +54.3% | -10.5% | 1.9% | |
| Mar 2026 | $22.8M | +21.3% | +22.6% | 2.4% | |
| Sep 2026 | $22.43M | -0.6% | +10.3% | 1.1% | |
| Jun 2026 | $18.04M | +15.0% | -8.7% | 1.2% | |
| Peer median (excluding EHC) | $46.11M | +10.9% | +9.4% | 2.2% | |
Competitors are the stored peer set for EHC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Cash & Equivalents | 49.4M | 21.8M | 104.2M | 85.4M | 102.9M |
| Short-term Investments | 0 | 0 | 37.6M | 0 | 42.2M |
| Net Receivables | 502.1M | 536.8M | 611.6M | 598.8M | 619.2M |
| Inventory | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets | 255M | 123.7M | 53.9M | 160.4M | 87.7M |
| Total Current Assets | 921.4M | 717.2M | 841.8M | 886.9M | 905.9M |
| Property, Plant & Equipment (Net) | 2.77B | 3.15B | 3.51B | 3.85B | 4.31B |
| Goodwill | 1.24B | 1.26B | 1.28B | 1.28B | 1.32B |
| Intangible Assets | 158.4M | 282.3M | 278.2M | 297.8M | 308.3M |
| Long-term Investments | 222.5M | 152.4M | 109.5M | 122.5M | 129.1M |
| Tax Assets | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Assets | 1.55B | 69.7M | 82.1M | 96.7M | 114.6M |
| Total Non-current Assets | 5.94B | 4.92B | 5.26B | 5.65B | 6.18B |
| Total Assets | 6.86B | 5.64B | 6.1B | 6.53B | 7.09B |
| Account Payables | 134M | 132.9M | 170M | 171M | 178.2M |
| Short-term Debt | 18.7M | 25.2M | 48.9M | 114.9M | 70.1M |
| Tax Payables | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue | 0 | 0 | 0 | 0 | 0 |
| Other Current Liabilities | 264.1M | 181.1M | 230M | 505.1M | 588.1M |
| Total Current Liabilities | 748.8M | 575.9M | 656.4M | 841M | 836.4M |
| Long-term Debt | 2.85B | 2.74B | 2.37B | 2.06B | 2.18B |
| Deferred Tax Liabilities | 0 | 83M | 87M | 105.2M | 126.8M |
| Deferred Revenue (Non-current) | 0 | 0 | 0 | 0 | 0 |
| Other Non-current Liabilities | 296.8M | 174.2M | 177.9M | 190.4M | 206.9M |
| Total Non-current Liabilities | 3.72B | 3.2B | 3.15B | 2.84B | 2.98B |
| Total Liabilities | 4.47B | 3.77B | 3.81B | 3.69B | 3.81B |
| Common Stock | 1.1M | 1.1M | 1.2M | 1.2M | 1.2M |
| Retained Earnings | 141.8M | 115.7M | 406.5M | 796.7M | 1.29B |
| Accumulated OCI | 0 | 0 | 0 | 0 | 500K |
| Other Stockholders Equity | (1) | 0 | 0 | 0 | 0 |
| Minority Interest | 487.9M | 551.6M | 649.7M | 782.2M | 837.6M |
| Total Equity | 2.4B | 1.86B | 2.3B | 2.85B | 3.28B |
| Total Debt | 3.48B | 2.99B | 2.93B | 2.71B | 2.71B |
| Net Debt | 3.43B | 2.97B | 2.83B | 2.63B | 2.61B |
Encompass Health Corporation
NYSE:EHC
Intrinsic Alpha fair value
Locked
Current Price
$134.93
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.